๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 139 Shenzhen 10 Fuzhou 4 Xi'an 4 Chongqing 4
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158 Clear sponsor filter
Site location
Beijing139 Shenzhen10 Fuzhou4 Xi'an4 Chongqing4
All 47 locations
Target enrolment
to

Trials with a site in Beijing

139 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Oliceridine Versus Sufentanil Analgesia for Postoperative Patients With Obstructive Sleep Apnea
NCT07753785Obstructive Sleep Apnea, Postoperative Analgesia, Oliceridine, Sufentanil
DrugsOliceridine·Sufentanil
Peking University First Hospital
Observational
851
Beijing
2026-09
Recruiting
GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma
NCT07795437Hepatocellular Carcinoma (HCC)
Peking University First Hospital
Not applicable
100
Beijing
2026-08-25
Recruiting
Perioperative Transcranial Photobiomodulation and Delayed Neurocognitive Recovery in Older Patients
NCT07736092Older Adults, Surgery, Transcranial Photobiomodulation, Delayed Neurocognitive Recovery
Peking University First Hospital
Not applicable
130
Beijing
2026-08-05
Not yet open
Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )
NCT07720921Urothelial Carcinoma of the Renal Pelvis and Ureter, Neoadjuvant Therapy
Peking University First Hospital
Phase 2
20
Beijing
2026-08-01
By invitation
Long-Term Follow-Up Study for RB001 Gene Therapy Study in Children With SHANK3-related Phelan McDermid Syndrome (PMS)
NCT07690527SHANK3 Haploinsufficiency, Phelan-McDermid Syndrome
Peking University First Hospital
Phase 1
8
Beijing
2026-08-01
Not yet open
Dexmedetomidine-Esketamine Combination on Depression and Anxiety After Laparoscopic Ureteral Reconstruction
NCT07753772Ureteral Stricture, Dexmedetomidine, Esketamine, Depressive Symptoms
DrugCombined dexmedetomidine-esketamine administration
Peking University First Hospital
Phase 4
658
Beijing
2026-08
Not yet open
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery
NCT07643792Fascia Iliaca Block, Liposomal Bupivacaine, Postoperative Pain, Hip Surgery
Drugs(plain bupivacaine·Liposomal bupivacaine
Peking University First Hospital
Phase 4
148
Beijing
2026-08
Not yet open
Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)
NCT07717580Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Primary Cutaneous Anaplastic Large Cell Lymphoma
DrugsBrentuximab Vedotin·Lisaftoclax
Peking University First Hospital
Phase 2
46
Beijing
2026-07-31
Not yet open
GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders
NCT07660939Plasma Cell Disorders, Multiple Myeloma (MM)
Peking University First Hospital
Phase 1
50
Beijing
2026-06-25
Recruiting
hUC-MSC-Exosomes for T2DM - Safety & Efficacy
NCT07693036Type 2 Diabetes Mellitus (T2DM)
Peking University First Hospital
Phase 1/2
66
Beijing
2026-06-05
Not yet open
Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery
NCT07576517Older Patients, Surgery, Dexmedetomidine, Esketamine
DrugDex-Esk
Peking University First Hospital
Phase 4
1,160
Beijing, Fuzhou, Shenzhen, Xi'an, Hangzhou
2026-06
Not yet open
Targeted Temperature Management on Delayed Neurocognitive Recovery in Older Patients After Major Cancer Surgery
NCT07655687Elderly Patients, Cancer Surgery, Hypothermia, Accidental, Targeted Temperature Management
Peking University First Hospital
Not applicable
1,512
Beijing, Shenzhen
2026-06
Not yet open
Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery
NCT07576543Older Patients, Surgery, Dexmedetomidine, Esketamine
DrugDex-Esk
Peking University First Hospital
Phase 4
1,160
Beijing, Fuzhou, Shenzhen, Xi'an, Hangzhou
2026-06
Not yet open
Intranasal Esketamine-dexmedetomidine Combination and Postpartum Depression
NCT07639099Parturients, Depressive Symptoms, Esketamine, Dexmedetomidine
Peking University First Hospital
Phase 4
164
Beijing
2026-06
Not yet open
Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With Mild-to-moderate Cognitive Impairment
NCT07610343Older Adults, Cognitive Impairment, Sleep Disorders, Dexmedetomidine
Peking University First Hospital
Phase 4
60
Beijing
2026-06
Not yet open
Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma
NCT07498907Upper Tract Urothelial Carcinoma
DrugsDisitamab Vedotin·Gemcitabine·Carboplatin
Peking University First Hospital
Phase 2
192
Beijing
2026-05-01
Recruiting
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
NCT07557225Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC), Colorectal Cancer, Cervical Cancer
Peking University First Hospital
Not applicable
200
Beijing
2026-04-27
Recruiting
Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication
NCT07439445Helicobacter Pylori Infection
Peking University First Hospital
Not applicable
70
Beijing
2026-04-25
Recruiting
Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery
NCT07525986Laparoscopic Surgery, Visceral Pain, Postoperative, Anrikefon, Patient-controlled Intravenous Analgesia
DrugsAnrikefon·Morphine
Peking University First Hospital
Phase 4
140
Beijing
2026-04-14
Recruiting
Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients
NCT07479602Adenotonsillectomy, Children, Intranasal Administration, Dexmedetomidine
Peking University First Hospital
Phase 4
160
Beijing
2026-04-07
Not yet open
Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma
NCT07504939Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy, Upper Tract Urothelial Carcinoma
Peking University First Hospital
Observational
36
Beijing
2026-04-01
Recruiting
68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma
NCT07774533Osteosarcoma, Osteosarcoma, Recurrent, Refractory
Peking University First Hospital
Phase EARLY_PHASE1
16
Beijing
2026-04-01
Not yet open
Anesthesia Maintenance With Target-controlled Infusion of Propofol and Remifentanil at Fixed Ratio
NCT07479719Elderly, Surgery, Depth of Anesthesia, Total Intravenous Anesthesia
Peking University First Hospital
Phase 4
200
Beijing
2026-04
Not yet open
Impact of Esketamine on Delayed Neurocognitive Recovery in Older Patients
NCT07523334Elderly, Noncardiac Surgery, Delayed Neurocognitive Recovery, Postoperative Delirium
Peking University First Hospital
Phase 4
120
Beijing, Tanjing
2026-04
Not yet open
Dexmedetomidine-esketamine Combination and Chronic Postsurgical Pain After Spinal Surgery
NCT07525999Spinal Surgery, Pain Intensity, Dexmedetomidine, Esketamine
DrugCombined dexmedetomidine-esketamine administration
Peking University First Hospital
Phase 4
274
Beijing
2026-04
Not yet open
Dexmedetomidine-esketamine Combination and Moderate-to-severe Pain After Spinal Surgery
NCT07523321Spinal Surgery, Pain Intensity, Dexmedetomidine, Esketamine
DrugCombined dexmedetomidine-esketamine administration
Peking University First Hospital
Phase 4
274
Beijing
2026-04
Not yet open
A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy
NCT07464119Diabetes Mellitus
Peking University First Hospital
Not applicable
30
Beijing
2026-03-16
Recruiting
Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
NCT07460843Prostate Cancer (Diagnosis)
Peking University First Hospital
Not applicable
592
Beijing
2026-03-01
Recruiting
The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease
NCT07374601Peripheral Artery Disease
Peking University First Hospital
Observational
300
Beijing
2026-02-08
Not yet open
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
NCT07422701Portal Vein Thrombosis, Liver Cirrhosis
Peking University First Hospital
Observational
2,522
Beijing, Shenzhen, Hengshui, Qinhuangdao, Wuxi, Qingdao
2026-02-01
Not yet open
Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy
NCT07276919Acute Urinary Retention, LUTS(Lower Urinary Tract Symptoms)
DrugTamsulosin
Peking University First Hospital
Phase 4
1,844
Beijing
2026-02-01
Recruiting
Site of Tracheal Extubation and Operating Room Efficiency During Robot-assisted Surgery
NCT07332806Robotic Surgical Procedures, Airway Extubation, Operating Rooms, Anesthesia Recovery Period
Peking University First Hospital
Not applicable
218
Beijing
2026-01-12
Active, closed
LishitonglinUS-01 Trial
NCT07769060Urethra Stricture
Peking University First Hospital
Phase 2
120
Beijing
2026-01-09
Recruiting
Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery
NCT07308756General Anesthesia, Surgery, Dexmedetomidine, Esketamine
DrugsEsketamine·Dexmedetomidine
Peking University First Hospital
Phase 4
316
Beijing
2026-01-05
Active, closed
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer
NCT07597369Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Cancer (mCRPC)
Peking University First Hospital
Observational
1,600
Beijing
2026-01-01
Not yet open
Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019
NCT07282197Prostate Cancer
DrugDarolutamide
Peking University First Hospital
Phase 2
40
Beijing
2026-01
Recruiting
68Ga-BCMA PET/CT in Multiple Myeloma
NCT07319897Multiple Myeloma, Multiple Myeloma and Malignant Plasma Cell Neoplasms, Multiple Myeloma and Plasma Cell Neoplasm
Peking University First Hospital
Phase 2/3
300
Beijing, Shijiazhuang, Jilin City
2025-12-25
Recruiting
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
NCT07570212Parkinson's Disease, Multiple System Atrophy, Progressive Supranuclear Palsy
Peking University First Hospital
Not applicable
50
Beijing
2025-12-22
Recruiting
A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis
NCT07215494Light Chain (AL) Amyloidosis, MRD
Peking University First Hospital
Not applicable
50
Beijing
2025-12-15
By invitation
Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer
NCT07386704Pancreatic Cancer Non-resectable
DrugNimotuzumab
Peking University First Hospital
Phase 2
30
Beijing
2025-12-09
Recruiting
Diagnostic Value of 68Ga-Pentixafor PET/CT in Adrenal Tumors With Aldosterone and Cortisol Cosecretion
NCT07605156Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion
Peking University First Hospital
Observational
130
Beijing
2025-12-01
Recruiting
A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.
NCT06641648Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) Relapse, NK Cell
Peking University First Hospital
Phase 1
12
Beijing
2025-11-01
Recruiting
CAIX PET/ CT Guided Radiation Therapy in CcRCC.
NCT07540260Radiation Therapy, Metastatic Renal Cancer, Recurrent Renal Cell Cancer
Peking University First Hospital
Not applicable
70
Beijing
2025-11-01
Not yet open
Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU Patients
NCT06468436Aged, Intensive Care Units, Ventilators, Mechanical, Dexmedetomidine
DrugsDexmedetomidine-esketamine combination·Dexmedetomidine
Peking University First Hospital
Not applicable
1,508
Beijing, Tianjin
2025-11
Recruiting
68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
NCT07508852SCLC, SCLC, Extensive Stage, SCLC, Limited Stage, Small Cell Lung Cancer
Peking University First Hospital
Phase 1/2
30
Beijing
2025-10-22
Recruiting
Artificial Intelligence Used in Screening Adrenal Nodules
NCT07198152Adrenal Incidentalomas, Thoracic CT-scan
Peking University First Hospital
Observational
600
Beijing
2025-09-01
Not yet open
Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy
NCT05576766Prostate Cancer, Robot-Assisted Laparoscopic Radical Prostatectomy, Enhanced Recovery After Surgery (ERAS) Protocol, Prehabilitation
Peking University First Hospital
Not applicable
54
Beijing
2025-09
Not yet open
A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Renal Artery Stenting Among Atherosclerosis Renal-vascular Hypertension Patients
NCT07111442Renal Artery Stenosis Atherosclerotic, Secondary Hypertension Renal Arterial
Peking University First Hospital
Not applicable
200
Beijing
2025-08-30
Recruiting
Multi-omics Studies of Primary Aldosteronism
NCT07111351Primary Aldosteronism
Peking University First Hospital
Observational
400
Beijing
2025-08-15
Recruiting
Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease
NCT07181525Inflamatory Bowel Disease
Peking University First Hospital
Observational
200
Beijing
2025-08-15
Recruiting
Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients
NCT07144696Type 1 Diabetes Mellitus
Peking University First Hospital
Not applicable
150
Beijing
2025-08-05
Recruiting
Novel Biomarkers and Postoperative Kidney Injury in Radical Nephrectomy
NCT07088874Nephrectomy, Acute Kidney Injury, Biomarker
Peking University First Hospital
Observational
60
Beijing
2025-08-02
By invitation
Ureteroscopy Combined With Negative Pressure Sheath Treatment of Kidney Stones
NCT06938113Kidney Calculi
Peking University First Hospital
Observational
115
Beijing
2025-07-28
Recruiting
Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery
NCT06482749Older Patients, Cognitive Impairment, Repetitive Transcranial Magnetic Stimulation, Delayed Neurocognitive Recovery
Peking University First Hospital
Not applicable
568
Beijing, Shenzhen, Xi'an
2025-07-28
By invitation
A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy
NCT07135219Immunoglobulin A Nephropathy (IgAN)
DrugCizutamig
Peking University First Hospital
Phase EARLY_PHASE1
15
Beijing
2025-07-16
Active, closed
Telitacicept for PGNMID: A Single-Arm Study
NCT07111338Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
DrugTelitacicept
Peking University First Hospital
Phase 2
10
Beijing
2025-07-12
Recruiting
Development, Application, and Mechanistic Investigation of a Novel Minimally-Invasive Bidirectional Epidural Cerebellar Stimulation Technique for Cerebellar Cognitive Affective Syndrome
NCT07166432Cerebellar Atrophy, Etiology, Physiopathology
Peking University First Hospital
Observational
200
Beijing
2025-06-28
Active, closed
RB001 Gene Therapy Study in Children With SHANK3-related Phelan-McDermid Syndrome (PMS)
NCT07014020Phelan-McDermid Syndrome, SHANK3 Haploinsufficiency
Peking University First Hospital
Phase 1
8
Beijing
2025-06-16
Not yet open
Azole Susceptibility and Resistance Mechanisms Surveys in Pathogenic Fungi by the CARST-fungi (2023-2024)
NCT06969703Fungal Disease
Peking University First Hospital
Observational
30
Beijing
2025-06-10
Recruiting
Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer
NCT07015138Prostate Cancer, Oligometastatic Prostate Cancer
Peking University First Hospital
Not applicable
390
Beijing
2025-06-01
Recruiting
68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors
NCT07331532Breast Neoplasmsใ€Lung Neoplasmsใ€Pancreatic Neoplasms
Peking University First Hospital
Observational
10
Beijing
2025-06-01
Recruiting
Prospective Multicenter Registry Study of Multiple System Atrophy in China
NCT07644013Multiple System Atrophy, Parkinson's Disease, Atypical Parkinsonism
Peking University First Hospital
Observational
214
Beijing
2025-06-01
Recruiting
Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study
NCT07111364Deep Learning, Ultrasound, Bladder Cancer
Peking University First Hospital
Observational
400
Beijing
2025-05-27
Active, closed
The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer
NCT06824259Prostate Cancer
Peking University First Hospital
Not applicable
400
Beijing
2025-05-14
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation and Quality of Recovery After Major Noncardiac Surgery
NCT06957912Vagus Nerve Stimulation, Transcutaneous Electric Nerve Stimulation, Noncardiac Surgery, Quality of Recovery
Peking University First Hospital
Not applicable
320
Beijing
2025-05-13
Recruiting
Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy
NCT06895538Leukemia, MDS, Lymphoma
Peking University First Hospital
Phase 2/3
24
Beijing
2025-05-03
Recruiting
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
NCT06717113Multiple Myeloma and Malignant Plasma Cell Neoplasms
DrugFluorodeoxyglucose
Peking University First Hospital
Phase EARLY_PHASE1
50
Beijing
2025-04-15
Recruiting
Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
NCT06901960Chronic Kidney Disease (Stages 3b-5)
Peking University First Hospital
Not applicable
1,066
Beijing, Nanning, Wuhan
2025-04-02
Recruiting
Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
NCT06924359Alzheimer's Disease (AD)
Peking University First Hospital
Observational
200
Beijing
2025-03-19
Recruiting
Dexmedetomidine-Esketamine Combination and Sleep Disturbances After Major Noncardiac Surgery
NCT06859892Adults, Major Noncardiac Surgery, Dexmedetomidine, Esketamine
DrugDexmedetomidine-esketamine combination
Peking University First Hospital
Phase 4
476
Beijing
2025-03-18
Recruiting
Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy
NCT05149196Nephrectomy, Nephroureterectomy, Hemodynamic Management, Acute Kidney Injury
Peking University First Hospital
Not applicable
1,724
Beijing
2025-02-10
Recruiting
Optimizing Prostate Biopsy Schemes in Men With Multiple MRI Visible Lesions
NCT06841211Prostate Cancer
Peking University First Hospital
Not applicable
572
Beijing
2025-02-01
Recruiting
Diagnosis and Allergen Identification of Perioperative Anaphylaxis
NCT06793163Perioperative/Postoperative Complications, Anaphylaxis, Tryptase, Allergens
Peking University First Hospital
Observational
115
Beijing
2025-01-25
Recruiting
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
NCT06722586Antiphospholipid (aPL)-Positive, Thrombocytopaenia
DrugsRapamycin·Sirolimus
Peking University First Hospital
Phase 4
84
Changsha, Jinan, Chengdu, รœrรผmqi, Wenzhou, Beijing, Shanghai
2025-01-07
Recruiting
Remimazolam and Emergence Delirium in Pediatrics
NCT07046364Pediatric, Neurosurgery, Sevoflurane Anesthesia, Remimazolam
DrugRemimazolam
Peking University First Hospital
Phase 4
248
Beijing
2025-01-01
Recruiting
Impact of Severe Obstructive Sleep Apnea-Hypopnea Syndrome on Auditory-Cognitive Processing
NCT07039500Obstructive Sleep Apnea, Auditory Processing Disorder
Peking University First Hospital
Observational
100
Beijing
2024-12-11
Recruiting
Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer
NCT06684652Prostate Cancer
Peking University First Hospital
Not applicable
300
Beijing
2024-12-01
Active, closed
Evaluating the Effectiveness of Intervention Based on the Model of Occupational Harmony in Patients With Sleep Disorders
NCT06558929Circadian Rhythm Sleep-Wake Disorder
Peking University First Hospital
Not applicable
40
Beijing
2024-11-01
Recruiting
Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma
NCT06348264Salivary Gland Neoplasm Duct
DrugsLeuprolide Acetate·Rezvilutamide
Peking University First Hospital
Phase 2
37
Beijing
2024-10-10
Recruiting
A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjects
NCT06669429Dyslipidemia
Peking University First Hospital
Phase 1
72
Beijing
2024-09-25
By invitation
Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors
NCT07182175Primary Aldosteronism, Adrenal Tumor, Cushing s Syndrome, Pheochromocytoma/Paraganglioma (PPGL)
Peking University First Hospital
Observational
150
Beijing
2024-09-19
Recruiting
Distribution of Mood and Personality Characteristics and Their Influence on Treatment Compliance
NCT07101796Personality, Patient Compliance, Anxiety, Depression
Peking University First Hospital
Observational
200
Beijing
2024-09-14
Recruiting
Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT
NCT07166445Carcinoma, Renal Cell, Diagnostic Imaging, Pathology, Deep Learning
Peking University First Hospital
Observational
1,000
Beijing
2024-09-01
Recruiting
Establishment of Screening Pathway for High-Risk Population of Type 1 Diabetes
NCT07468474Type 1 Diabetes Mellitus
Peking University First Hospital
Observational
340
Beijing
2024-09-01
Recruiting
Effect of the Postbiotics on Complications Treatment in Elderly Hemodialysis Patients
NCT06975995Hemodialysis Complication
Peking University First Hospital
Not applicable
60
Beijing
2024-08-01
Recruiting
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
NCT06519760Carbonic Anhydrase IX, PET-CT, Clear Cell Renal Cell Carcinoma
Peking University First Hospital
Not applicable
200
Beijing
2024-07-30
Recruiting
Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
NCT06482645Prostate Cancer
Peking University First Hospital
Not applicable
640
Beijing
2024-07-01
Not yet open
Neoadjuvant Radiotherapy for High-risk UTUC
NCT06472752Urothelial Carcinoma of the Renal Pelvis and Ureter
Peking University First Hospital
Observational
40
Beijing
2024-06-30
Recruiting
Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort
NCT06399185Urinary Catheter, Catheter-related Bladder Discomfort, Dexmedetomidine, Esketamine
Peking University First Hospital
Phase 4
1,740
Beijing, Shenzhen
2024-06-06
Recruiting
Fractional Flow Reserve-guided Stenting Versus Medical Therapy in Atherosclerosis Renal Artery Stenosis
NCT06447740Renal Artery Stenosis Atherosclerotic, Secondary Hypertension Renal Arterial
DrugDopamine
Peking University First Hospital
Not applicable
200
Beijing
2024-06-03
Recruiting
Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival
NCT06256354Cancer Surgery, Intraoperative Hypothermia, Targeted Temperature Management, Postoperative Delirium
Peking University First Hospital
Not applicable
3,992
Chizhou, Hefei, Maโ€™anshan, Beijing, Chongqing, Shenzhen, Shijiazhuang, Harbin
2024-05-29
Recruiting
PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression
NCT06289517Neoplasms
Peking University First Hospital
Not applicable
30
Beijing
2024-05-28
Recruiting
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
NCT06436677Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T Cell Lymphoma
Peking University First Hospital
Observational
100
Beijing
2024-05-09
Recruiting
Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis
NCT06392737Prostate Cancer
Peking University First Hospital
Not applicable
360
Beijing
2024-05-01
By invitation
FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis
NCT06563765CKD, Renal Fibrosis
Peking University First Hospital
Not applicable
150
Beijing
2024-04-10
By invitation
The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease
NCT06841224Peritoneal Dialysis, Polycystic Kidney Diseases
Peking University First Hospital
Observational
30
Beijing
2024-04-01
Recruiting
PET Imaging Study of 68Ga-NB381 in Multiple Myeloma
NCT06385652Multiple Myeloma
Peking University First Hospital
Phase EARLY_PHASE1
30
Beijing
2024-04-01
Recruiting
A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)
NCT06991868NMIBC, MIBC, UTUC
Peking University First Hospital
Observational
300
Beijing
2024-03-01
Recruiting
Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
NCT06489080Acute Myocardial Infarction, Coronary Artery Disease
Peking University First Hospital
Observational
10,000
Beijing
2024-03-01
Recruiting
A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery
NCT06210490Upper Urinary Tract Urothelial Carcinoma
DrugDisitamab Vedotin
Peking University First Hospital
Phase 2
60
Beijing
2024-02-20
Rows per page Showing 1–100 of 139
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 139 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

91 of the 139 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 28 have not yet opened recruitment, 13 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 139 studies
PhaseStudiesRecruitingShare
Not applicable453532.4%
Observational453332.4%
Phase 4241017.3%
Phase 21248.6%
Phase 1523.6%
Phase EARLY_PHASE1432.9%
Phase 1/2221.4%
Phase 2/3221.4%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Peking University First Hospital13991
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.